CENPA
Histone H3-like centromeric protein A
Also known as: CenH3, CENP-A, CENPA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49450
- Gene
- CENPA
- Ensembl
- ENSG00000115163
- Chromosome
- 2
- Canonical length
- 140 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Centromeres are the differentiated chromosomal domains that specify the mitotic behavior of chromosomes. This gene encodes a centromere protein which contains a histone H3 related histone fold domain that is required for targeting to the centromere. Centromere protein A is proposed to be a component of a modified nucleosome or nucleosome-like structure in which it replaces 1 or both copies of conventional histone H3 in the (H3-H4)2 tetrameric core of the nucleosome particle. The protein is a replication-independent histone that is a member of the histone H3 family. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
140 residues, UniProt reviewed canonical sequence.
>P49450|CENPA
1 MGPRRRSRKP EAPRRRSPSP TPTPGPSRRG PSLGASSHQH SRRRQGWLKE IRKLQKSTHL
61 LIRKLPFSRL AREICVKFTR GVDFNWQAQA LLALQEAAEA FLVHLFEDAY LLTLHAGRVT
121 LFPKDVQLAR RIRGLEEGLGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CENPA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- thymus: 12 nTPM
- tonsil: 7.8 nTPM
- lymph node: 6.8 nTPM
- duodenum: 3.9 nTPM
- appendix: 3.8 nTPM
- esophagus: 3.7 nTPM
Single-cell type
- monocyte progenitors: 69 nCPM
- gastric progenitor cells: 68 nCPM
- differentiating spermatogonia: 50 nCPM
- enteric transient amplifying cells: 44 nCPM
- esophageal basal cells: 43 nCPM
- migrating cytotrophoblasts: 40 nCPM
Immune cell
- MAIT T-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- thalamus: 0.3 nTPM
- cerebellum: 0.2 nTPM
- cerebral cortex: 0.2 nTPM
- basal ganglia: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- pons: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CENPA.
Disease | ImmuneIEDB
Conditions an epitope on CENPA was assayed in.
- systemic scleroderma B cell
- systemic lupus erythematosus B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against CENPA are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for CENPA from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
22 publications
- A 17-kD centromere protein (CENP-A) copurifies with nucleosome core particles and with histones.
1987 · J Cell Biol · RCR 5.9 · 357 citations - Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer.
2003 · Cancer Res · RCR 4 · 263 citations - Proteomics analysis of the centromere complex from HeLa interphase cells: UV-damaged DNA binding protein 1 (DDB-1) is a component of the CEN-complex, while BMI-1 is transiently co-localized with the centromeric region in interphase.
2004 · Genes Cells · RCR 2.3 · 152 citations - Birth, evolution, and transmission of satellite-free mammalian centromeric domains.
2018 · Genome Res · RCR 2.1 · 60 citations - Centromere sliding on a mammalian chromosome.
2015 · Chromosoma · RCR 1.7 · 53 citations
Show 17 more
- Robertsonian Fusion and Centromere Repositioning Contributed to the Formation of Satellite-free Centromeres During the Evolution of Zebras.
2022 · Mol Biol Evol · RCR 1.7 · 21 citations - Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
2012 · J Rheumatol · RCR 1.5 · 43 citations - Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
2011 · Clin Chim Acta · RCR 1.1 · 34 citations - Constitutive centromere-associated network controls centromere drift in vertebrate cells.
2017 · J Cell Biol · RCR 0.9 · 31 citations - Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin.
2016 · Autoimmun Rev · RCR 0.7 · 18 citations - Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.
2016 · Medicine (Baltimore) · RCR 0.6 · 14 citations - Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
2010 · Arthritis Res Ther · RCR 0.6 · 20 citations - Detection of IgE-autoantibodies to nuclear antigens in patients with systemic sclerosis and analysis of their clinical relevance.
2024 · Clin Exp Rheumatol · RCR 0.5 · 3 citations - Microinjection of antibodies to centromere protein CENP-A arrests cells in interphase but does not prevent mitosis.
1998 · Chromosoma · RCR 0.5 · 30 citations - Anticentromere antibody induced by immunization with centromere protein a and Freund's complete adjuvant may interfere with mouse oocyte meiosis.
2021 · Reprod Biol Endocrinol · RCR 0.4 · 6 citations - Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis.
2013 · PLoS One · RCR 0.4 · 10 citations - A charged segment mainly composed of basic amino acids forms an autoepitope of CENP-A.
1996 · Clin Immunol Immunopathol · RCR 0.4 · 13 citations - Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis.
2013 · Arthritis Res Ther · RCR 0.2 · 6 citations - An Exploration of the Impact of Anticentromere Antibody on Early-Stage Embryo.
2017 · J Immunol Res · RCR 0.2 · 5 citations - Cross-reactive anti-CENP-A autoantibodies induce analytic interference in anti-TIF1γ detection using line-dot immunoassay.
2021 · Rheumatology (Oxford) - Anti-Centromere Protein A Antibody Disrupts the Competence of Mouse Oocytes Matured In Vitro.
2024 · Am J Reprod Immunol - Novel Biomarker for Antimitochondrial Antibodies in Systemic Sclerosis Patients.
2026 · J Immunol Res
Reference: B cellIEDB
7 publications
- Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis.
2012 · Autoimmun Rev · RCR 1 · 35 citations - Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies.
2006 · J Autoimmun · RCR 0.7 · 26 citations - A population of autoantibodies against a centromere-associated protein A major epitope motif cross-reacts with related cryptic epitopes on other nuclear autoantigens and on the Epstein-Barr nuclear antigen 1.
2001 · J Mol Med (Berl) · RCR 0.6 · 28 citations - Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis.
2002 · Arthritis Rheum · RCR 0.5 · 22 citations - Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis.
2013 · PLoS One · RCR 0.4 · 10 citations
Show 2 more
- The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3).
2010 · Clin Immunol · RCR 0.3 · 9 citations - Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis.
2013 · Arthritis Res Ther · RCR 0.2 · 6 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.73
- DepMap mean gene effect
- -0.92
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- CENP-A containing chromatin assembly
- establishment of mitotic spindle orientation
- kinetochore assembly
- mitotic cytokinesis
- protein localization to CENP-A containing chromatin
- protein localization to chromosome, centromeric region
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CENPA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CENPA as an antibody target. Whether an autoantibody or antibody against CENPA could matter depends on whether native CENPA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CENPA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CENPA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...